Mechanisms of neurodegeneration in amyotrophic lateral sclerosis

被引:0
|
作者
Cluskey, S [1 ]
Ramsden, DB [1 ]
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England
来源
关键词
amyotrophic lateral sclerosis; motor neurone disease; neurodegeneration;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Amyotrophic lateral sclerosis (ALS) is the most common variant of motor neurone disease affecting adults that usually strikes during mid to late life. Its aetiology is still poorly understood, although a major breakthrough came with the discovery that mutations in the Cu/Zn superoxide dismutase (SOD1) gene affect approximately 20% of patients with familial ALS. Experiments using both transgenic mice and ALS tissues have been useful in delineating other genetic defects in ALS. However, because only a subset of cases can be attributed to one particular molecular defect (such as mutation of SOD1 or the gene encoding neurofilament H), the aetiology of ALS is likely to be multifactorial. This review discusses the major mechanisms of neurodegeneration in ALS, such as oxidative stress, glutaminergic excitotoxicity, damage to vital organelles, and aberrant protein aggregation.
引用
收藏
页码:386 / 392
页数:7
相关论文
共 50 条
  • [41] Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era
    Paez-Colasante, Ximena
    Figueroa-Romero, Claudia
    Sakowski, Stacey A.
    Goutman, Stephen A.
    Feldman, Eva L.
    NATURE REVIEWS NEUROLOGY, 2015, 11 (05) : 266 - 279
  • [42] PATHOGENIC MECHANISMS IN SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    EISEN, A
    KRIEGER, C
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1993, 20 (04) : 286 - 296
  • [43] Pathophysiological mechanisms of oropharyngeal dysphagia in amyotrophic lateral sclerosis
    Ertekin, C
    Aydogdu, I
    Yüceyar, N
    Kiylioglu, N
    Tarlaci, S
    Uludag, B
    BRAIN, 2000, 123 : 125 - 140
  • [44] Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era
    Ximena Paez-Colasante
    Claudia Figueroa-Romero
    Stacey A. Sakowski
    Stephen A. Goutman
    Eva L. Feldman
    Nature Reviews Neurology, 2015, 11 : 266 - 279
  • [45] Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis
    Nguyen, Lien
    CELLS, 2024, 13 (11)
  • [46] Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis
    Jimenez-Pacheco, Alba
    Franco, Jaime M.
    Lopez, Soledad
    Miguel Gomez-Zumaquero, Juan
    Magdalena Leal-Lasarte, Maria
    Caballero-Hernandez, Diana E.
    Cejudo-Guillen, Marta
    Pozo, David
    NEUROEPIGENOMICS IN AGING AND DISEASE, 2017, 978 : 255 - 275
  • [47] Epigenetic mechanisms in amyotrophic lateral sclerosis: A short review
    Dolinar, Ana
    Ravnik-Glavac, Metka
    Glavac, Damjan
    MECHANISMS OF AGEING AND DEVELOPMENT, 2018, 174 : 103 - 110
  • [48] Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis
    Gil-Bea, Francisco J.
    Aldanondo, Garazi
    Lasa-Fernandez, Haizpea
    Lopez De Munain, Adolfo
    Vallejo-Illarramendi, Ainara
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2017, 19
  • [49] Targeting multiple mechanisms to treat amyotrophic lateral sclerosis
    Heather Wood
    Nature Reviews Neurology, 2017, 13 (3) : 130 - 130
  • [50] Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis
    Shang, Yulei
    Huang, Eric J.
    BRAIN RESEARCH, 2016, 1647 : 65 - 78